Health Care

Waters Corp., an analytical laboratory instrument company based in Milford, has invested $5.8 million in expanding its research and development center in Wexford, Ireland, to expand its mass spectrometry technology.

On Sunday, 3,000 people took part in the 24th annual UMass Cancer Walk and Run, raising $700,000 for cancer trials at UMass Chan Medical School, according to a Tuesday press release.

Affyimmune Therapeutics, Inc., a Natick-based clinical stage biotech company specializing in solid cancer treatment, has named biotech entrepreneur and executive Robert Forrester to its board of directors.

A Sept. 22 study released by Worcester-based nonprofit Wake Up Narcolepsy has found physicians in and around Boston may know less about diagnosing narcolepsy than they think they do.

The Federal Emergency Management Agency will send another $2.2 million to the College of the Holy Cross in Worcester for the cost of testing students, faculty, and staff during the COVID-19 pandemic.

Researchers at UMass Chan Medical School are teaming up with pharmaceutical giant Pfizer and the U.S. Food and Drug Administration to study the effects of the COVID-19 drug Paxlovid on patients aged 18 and under.

Phio Pharmaceuticals Corp. named the chairman of its board to serve as interim executive chairman.

UMass Chan Medical School and a New Haven digital healthcare company are launching a new program to study the ability of virtual care to prevent acute care needs among people with COPD.

Marlborough-based medical technology company Hologic’s second annual Global Women’s Health Index reveals a lack of progress in women’s health care indicators worldwide.

Fallon Health has awarded $150,000 across 13 organizations as part of its 2022 Community Impact Grants.